To investigate the critical role of PTPN3 in ovarian cancer drug resistance and cell cycle progression, we examined the effects of silencing of PTPN3 on resistant ovarian cancer cell growth, migration and drug resistance. This evidence concerns the gene PTPN3 and ovarian cancer.